Trial Information
Serum Free Light Chain Ratio, Total Kappa/Lambda Ratio, and Immunofixation as Prognostic Factors in Multiple Myeloma.
Inclusion Criteria:
- Patients affected with Multiple Myeloma who underwent autologous or auto/allogenic
stem cell transplantation.
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Retrospective
Authority:
Italy: Ministry of Health
Study ID:
sFLC r, KLR and IFIX
NCT ID:
NCT00910078
Start Date:
Completion Date:
Related Keywords:
- Multiple Myeloma
- Total kappa and lambda ratio
- Stem cell transplantation
- Serum immunofixation
- Multiple Myeloma
- Neoplasms, Plasma Cell